Effectiveness of metyrapone in treating Cushing's Syndrome: a retrospective multicenter study in 195 patients.
Daniel, E Aylwin, S Mustafa, O Ball, S Munir, A Boelaert, K Chortis, V Cuthbertson, D Daousi, C Rajeev, S
Daniel, E
Aylwin, S
Mustafa, O
Ball, S
Munir, A
Boelaert, K
Chortis, V
Cuthbertson, D
Daousi, C
Rajeev, S
Citations
Altmetric:
Abstract
Cushing's syndrome is a severe condition with excess mortality and significant morbidity necessitating control of hypercortisolemia. There are few data documenting use of the steroidogenesis inhibitor metyrapone for this purpose.
Authors
Daniel, E
Aylwin, S
Mustafa, O
Ball, S
Munir, A
Boelaert, K
Chortis, V
Cuthbertson, D
Daousi, C
Rajeev, S
Davis, J
Cheer, K
Drake, W
Gunganah, K
Grossman, A
Gurnell, M
Powlson, A
Karavitaki, N
Huguet, I
Kearney, T
Mohit, K
Meeran, K
Hill, N
Rees, A
Lansdown, A
Trainer, Peter J
Minder, Anna-Elisabeth H
Newell-Price, J
Aylwin, S
Mustafa, O
Ball, S
Munir, A
Boelaert, K
Chortis, V
Cuthbertson, D
Daousi, C
Rajeev, S
Davis, J
Cheer, K
Drake, W
Gunganah, K
Grossman, A
Gurnell, M
Powlson, A
Karavitaki, N
Huguet, I
Kearney, T
Mohit, K
Meeran, K
Hill, N
Rees, A
Lansdown, A
Trainer, Peter J
Minder, Anna-Elisabeth H
Newell-Price, J
Description
Date
2015-09-09
Publisher
Collections
Keywords
Type
Article
Citation
Effectiveness of metyrapone in treating Cushing's Syndrome: a retrospective multicenter study in 195 patients. 2015: 20152616 J Clin Endocrinol Metab